Wecome Pharmaceutical Co Ltd (300878) - Total Liabilities

Latest as of September 2025: CN¥458.37 Million CNY ≈ $67.07 Million USD

Based on the latest financial reports, Wecome Pharmaceutical Co Ltd (300878) has total liabilities worth CN¥458.37 Million CNY (≈ $67.07 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Wecome Pharmaceutical Co Ltd - Total Liabilities Trend (2013–2024)

This chart illustrates how Wecome Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See Wecome Pharmaceutical Co Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Wecome Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wecome Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Solid Biosciences LLC NASDAQ:SLDB	USA	$48.76 Million
People & Technology Inc KQ:137400	Korea	₩1.14 Trillion
Fedbank Financial Services Limited NSE:FEDFINA	India	Rs106.53 Billion
Beijing Advanced Digital Technology Co Ltd SHE:300541	China	CN¥1.49 Billion
Redwood Trust Inc NYSE:RWT	USA	$25.86 Billion
Complete Logistic Services Bhd KLSE:5136	Malaysia	RM67.56 Million
Algoma Central Corporation TO:ALC	Canada	CA$762.36 Million
Shanghai Hollywave Electronic System Co. Ltd. A SHG:688682	China	CN¥228.04 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Wecome Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Wecome Pharmaceutical Co Ltd worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.45	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wecome Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wecome Pharmaceutical Co Ltd (2013–2024)

The table below shows the annual total liabilities of Wecome Pharmaceutical Co Ltd from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥478.50 Million ≈ $70.02 Million	-25.14%
2023-12-31	CN¥639.23 Million ≈ $93.54 Million	+27.27%
2022-12-31	CN¥502.25 Million ≈ $73.50 Million	+76.67%
2021-12-31	CN¥284.28 Million ≈ $41.60 Million	+16.32%
2020-12-31	CN¥244.39 Million ≈ $35.76 Million	-31.35%
2019-12-31	CN¥356.02 Million ≈ $52.10 Million	+43.97%
2018-12-31	CN¥247.29 Million ≈ $36.19 Million	+42.38%
2017-12-31	CN¥173.68 Million ≈ $25.42 Million	+66.61%
2016-12-31	CN¥104.25 Million ≈ $15.25 Million	+13.51%
2015-12-31	CN¥91.84 Million ≈ $13.44 Million	-3.14%
2014-12-31	CN¥94.82 Million ≈ $13.88 Million	+30.28%
2013-12-31	CN¥72.78 Million ≈ $10.65 Million	--

About Wecome Pharmaceutical Co Ltd

SHE:300878 China Biotechnology

Market Cap

$646.21 Million

CN¥4.42 Billion CNY

Market Cap Rank

#11129 Global

#3151 in China

Share Price

CN¥30.50

Change (1 day)

-2.27%

52-Week Range

CN¥15.29 - CN¥36.20

All Time High

CN¥52.21